IRIS
GENNARI, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.127
EU - Europa 9.722
AS - Asia 6.959
SA - Sud America 1.425
AF - Africa 234
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 13
Totale 32.511
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.957
CN - Cina 2.376
SG - Singapore 2.230
RU - Federazione Russa 2.082
GB - Regno Unito 1.679
IE - Irlanda 1.517
BR - Brasile 1.201
IT - Italia 1.018
UA - Ucraina 890
FR - Francia 685
VN - Vietnam 665
SE - Svezia 663
HK - Hong Kong 559
DE - Germania 525
KR - Corea 375
FI - Finlandia 342
IN - India 166
ZA - Sudafrica 97
TR - Turchia 96
BD - Bangladesh 94
CA - Canada 88
AR - Argentina 86
IQ - Iraq 67
NL - Olanda 56
ES - Italia 44
MX - Messico 44
ID - Indonesia 40
PL - Polonia 40
PK - Pakistan 39
JP - Giappone 34
CL - Cile 32
EC - Ecuador 32
NG - Nigeria 31
CZ - Repubblica Ceca 29
BE - Belgio 28
CO - Colombia 26
SA - Arabia Saudita 25
AT - Austria 24
UZ - Uzbekistan 24
KE - Kenya 22
AU - Australia 21
CI - Costa d'Avorio 19
NP - Nepal 19
LT - Lituania 18
VE - Venezuela 16
AE - Emirati Arabi Uniti 13
DZ - Algeria 13
JO - Giordania 13
MA - Marocco 13
MY - Malesia 13
IR - Iran 12
TN - Tunisia 12
EU - Europa 11
GR - Grecia 11
PE - Perù 11
DK - Danimarca 10
IL - Israele 10
JM - Giamaica 10
PH - Filippine 10
SY - Repubblica araba siriana 10
EG - Egitto 9
HU - Ungheria 9
PY - Paraguay 9
UY - Uruguay 9
AZ - Azerbaigian 8
DO - Repubblica Dominicana 7
ET - Etiopia 7
KZ - Kazakistan 7
NZ - Nuova Zelanda 7
OM - Oman 7
TH - Thailandia 7
GE - Georgia 6
KG - Kirghizistan 6
LV - Lettonia 6
CH - Svizzera 5
HN - Honduras 5
RS - Serbia 5
AM - Armenia 4
HR - Croazia 4
IM - Isola di Man 4
KH - Cambogia 4
PT - Portogallo 4
AL - Albania 3
BH - Bahrain 3
CR - Costa Rica 3
LB - Libano 3
LU - Lussemburgo 3
PA - Panama 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AO - Angola 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
EE - Estonia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MM - Myanmar 2
MN - Mongolia 2
Totale 32.477
Salva come PNG Salva come JPEG
Città #
Dallas 2.604
Dublin 1.500
Fairfield 1.487
Southend 1.395
Singapore 1.195
Ashburn 972
Jacksonville 706
Chandler 702
Woodbridge 660
Santa Clara 628
Wilmington 565
Houston 556
Moscow 545
Hong Kong 538
Seattle 532
Cambridge 527
Beijing 498
Hefei 464
Seoul 373
Princeton 316
San Jose 306
Ann Arbor 305
The Dalles 250
Siena 225
Nanjing 219
Ho Chi Minh City 211
Council Bluffs 191
Lauterbourg 188
Los Angeles 175
Helsinki 157
Hanoi 134
Boardman 104
Buffalo 99
San Diego 97
Shanghai 94
São Paulo 89
Milan 87
Nanchang 85
Johannesburg 78
New York 75
Dong Ket 72
Florence 72
London 72
Izmir 65
Munich 65
San Mateo 62
Shenyang 59
Rome 56
Redondo Beach 52
Tianjin 52
Columbus 49
Dearborn 47
Bengaluru 45
Orem 44
Rio de Janeiro 42
Hebei 41
Belo Horizonte 40
Jiaxing 38
Kunming 36
Changsha 34
Da Nang 33
San Francisco 32
Warsaw 32
Abuja 30
Tokyo 30
Frankfurt am Main 29
Brooklyn 28
Toronto 27
Brussels 26
Chennai 26
Chicago 26
Düsseldorf 26
Turku 26
Nuremberg 24
Redwood City 24
Brasília 23
Denver 23
Montreal 23
Lappeenranta 22
Málaga 22
Norwalk 22
Tashkent 22
Baghdad 21
Porto Alegre 21
Haiphong 20
Hangzhou 20
Jinan 20
Stockholm 20
Zhengzhou 20
Abidjan 19
Amsterdam 19
Atlanta 19
Manchester 19
Boston 18
Falls Church 18
Riyadh 18
Curitiba 17
Dhaka 17
Poplar 17
Fremont 16
Totale 21.890
Salva come PNG Salva come JPEG
Nome #
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) for the treatment of type 2 diabetes mellitus: friends or foes to bone health? a narrative review of clinical studies 1.229
null 398
Activation of the Wnt pathway by small peptides: rational design, synthesis and biological evaluation 324
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes 301
Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study 298
Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone 266
Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women 263
Aromatase activity and bone loss in men 251
Characteristics and familial aggregation of Paget's disease of bone in Italy 247
A non-synonymous TNFRSF11A variation increases NFkB activity and the severity of Paget's disease 245
Falls, fractures and vitamin D: a never-ending story? 245
Bazedoxifene for the prevention of postmenopausal osteoporosis 244
Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone. 240
Aromatase activity and bone homeostasis in men 238
Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease 233
The association of body composition and sexhormones with quantitative ultrasound parameters at the calcaneus and phalanxes in elderly women. 230
Age-related decline of bone mass and intestinal calcium absorption in normal males 230
Dual X-ray absorptiometry and bone ultrasonography in patients with Rett Syndrome 225
ZNF687 Mutations in Severe Paget Disease of Bone Associated with Giant Cell Tumor 221
The usefulness of quantitative ultrasound (QUS) measurements in the evaluation of skeletal status in newborns and in children 218
Absence of correlation between BMP-4 polymorphism and postmenopausal osteoporosis in Italian women 216
Endocrine actions of osteocalcin 216
Undiagnosed vertebral fractures influence quality of life in postmenopausal women with reduced ultrasound parameters. 214
A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. 214
Corretto uso dei marcatori del rimodellamento osseo 213
Aromatase activity and bone loss 211
Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls 210
Bone metabolism in men: role of aromatase activity 206
Vitamin D receptor genotypes and intestinal calcium absorption in postmenopausal women 201
Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget’s disease of bone 201
Longitudinal association between sex hormone levels, bone loss and bone turnover in elderly men. 201
Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women 198
SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone 197
Beyond glycemic control in diabetes mellitus: effects of incretin-based therapy on bone metabolism 197
Mutation of PFN1 gene in an early onset, polyostotic Paget-like disease 195
Appropriate models for novel osteoporosis drug discovery and future perspectives 193
Adiponectin may play a crucial role in the metabolic effects of GLP-1RAs treatment in patients with Type 2 Diabetes Mellitus: a preliminary longitudinal study 192
Mild brachydactyly type A1 maps to chromosome 2q35-q36 and is caused by a novel IHH mutation in a three generation family 191
Lasofoxifene, from the preclinical drug discovery to the treatment of postmenopausal osteoporosis 191
Misdiagnosis of vertebral fractures on local radiographic readings of the multicentre POINT (Prevalence of Osteoporosis in INTernal medicine) study 191
CALCITRIOLO E OSTEOPOROSI 189
The effects of zoledronic acid on serum lipids in multiple myeloma patients 187
Effect of electromagnetic fields on bone mineral density and biochemical markers of bone turnover in osteoporosis: a single-blind, randomized, pilot study 186
The combined use of ultrasound and densitometry in the prediction of vertebral fracture 186
Left ventricular hypertrophy differences in male professional runners and in young patients suffering from mild hypertension 183
Vitamin D receptor gene polymorphisms predict acquired resistance to clodronate treatment in patients with Paget's disease of bone 183
Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function 183
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene 180
Analysis of Usual Consumption of Vitamin D Among Adult Individuals in Italy 179
Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density 179
Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease 179
The impact of infarct size on regional and global left ventricular systolic function: a cardiac magnetic resonance imaging study 178
aromatase deficiency and male osteoporosis 177
Bona fide genetic associations with bone mineral density 175
Effect of electromagnetic fields on bone mineral density and biochemical markers of bone turnover in osteoporosis: a single-blind, randomized pilot study 175
Epidemiological, clinical, and genetic characteristics of Paget's disease of bone in a rural area of Calabria, Southern Italy 173
Preventive Role of Vitamin D Supplementation for Acute Phase Reaction after Bisphosphonate Infusion in Paget's Disease 173
Osteoporosis in men: pathophysiology and treatment 173
Pharmacokinetic evaluation of toremifene and its clinical implications for the treatment of osteoporosis 172
Quantitative ultrasound and dual-energy X-ray absorptiometry in the prediction of fragility fracture in men 171
The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone 171
Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis 171
Update on the pathogenesis and genetics of Paget's disease of bone 170
Bisphosphonates target B cells to enhance humoral immune responses 170
Membrane binding sites and non-genomic effects of estrogen in cultured human pre-osteoclastic cells 169
Feasibility of quantitative ultrasound measurements on the humerus of newborn infants for the assessment of the skeletal status. 169
Evidence for increased clinical severity of familial and sporadic Paget’s disease of bone in Campania, southern Italy 169
Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: epidemiology, clinical features and outcomes in the era of antimicrobial resistance 168
Update on the pharmacogenetics of the vitamin D receptor and osteoporosis 168
The relationship between plasma homocysteine levels and bone mineral density in post-menopausal women 168
Giant cell tumor occurring in familial Paget's disease of bone: report of clinical characteristics and linkage analysis of a large pedigree 167
Prevalence of Paget’s disease of bone in Italy 166
Apporto nutrizionale di vitamina D in Italia [Feeding and vitamin D in Italy] 165
Mechanisms of impaired bone strength in type 1 and 2 diabetes 165
Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk 165
Infection by CagA-Positive Helicobacter pylori Strains and Bone Fragility: A Prospective Cohort Study 165
Polymorphisms of the calcitonin receptor gene are associated with bone mineral density in postmenopausal Italian women 164
Idiopathic osteoporosis in men 163
Paget's disease of bone: epidemiology, pathogenesis and pharmacotherapy 163
Quantitative ultrasound and bone mineral density in patients with primary hyperparathyroidism before and after surgical treatment 162
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels 162
MicroRNAs in bone diseases 162
Does calcium supplementation reduce the risk of osteoporotic fracture and bone loss? 161
FokI polymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fractures in postmenopausal Italian women 161
Bone fragility in gastrointestinal disorders 159
Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosis 159
PTH in the pathogenesis and treatment of glucocorticoid-induced osteoporosis 158
Bone fragility in men: where are we? 157
Perspectives in the treatment and prevention of osteoporosis 157
Usefulness of bone quantitative ultrasound in management of osteoporosis in men 157
Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis 157
Genome-wide association identifies three new susceptibilityloci for Paget's disease of bone 156
Lasofoxifene: a new-generation SERM for the treatment of postmenopausal osteoporosis 156
Vitamin D Status in Paget Disease of Bone and Efficacy-Safety Profile of Cholecalciferol Treatment in Pagetic Patients with Hypovitaminosis D. 156
Ospemifene use in postmenopausal women 155
Paget’s disease of bone in Italy. 154
Diagnosis of Endocrine Disease: Evaluation of bone fragility in endocrine disorders. 154
Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries 153
Telomerase repeat amplification protocol (TRAP): A new molecular marker for parathyroid carcinoma 153
The effect of zoledronic acid on serum osteoprotegerin in early stage multiple myeloma 152
Totale 20.252
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.851
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021602 0 0 0 0 0 0 0 0 0 172 221 209
2021/20221.948 124 280 85 202 69 56 87 69 125 226 178 447
2022/20232.674 184 175 355 388 289 584 55 196 270 47 93 38
2023/20242.280 230 76 217 72 52 533 738 44 18 57 46 197
2024/20255.010 105 267 368 238 607 284 170 291 443 278 492 1.467
2025/202611.177 987 1.803 2.249 1.298 1.859 481 1.174 311 399 616 0 0
Totale 32.872